Clinical significance of epidermal growth factor receptor mutations in resected stage IA non-small cell lung cancer-Reference-Cited by-同舟云学术

Clinical significance of epidermal growth factor receptor mutations in resected stage IA non-small cell lung cancer

Published:2022 Issue:3 Volume:55 Page:109-115
ISSN:1682-606X
Container-title:Formosan Journal of Surgery
language:en
Short-container-title:

Author:

Tsai Yuan-Ming,Lin Kuan-Hsun,Kuo Yen-Shou,Lin Yu-Chieh,Chien Yu-Hsin,Chou Hsiu-Ping,Chen Ying-Yi,Huang Hsu-Kai,Wu Ti-Hui,Chang Hung,Lee Shih-Chun,Huang Tsai-Wang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference31 articles.

1. Development and outcomes of a comprehensive multidisciplinary incidental lung nodule and lung cancer screening program;LeMense;BMC Pulm Med,2020

2. Is limited pulmonary resection equivalent to lobectomy for surgical management of stage I non-small-cell lung cancer?;De Zoysa;Interact Cardiovasc Thorac Surg,2012

3. The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: A meta-analysis of literatures;He;Transl Lung Cancer Res,2019

4. Genomic landscape of lung adenocarcinoma in East Asians;Chen;Nat Genet,2020

5. Biological and clinical implications of EGFR mutations in lung cancer;Mitsudomi;Int J Clin Oncol,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGFR co-mutation is associated with the risk of recurrence in invasive lung adenocarcinoma with the micropapillary component;Asian Journal of Surgery;2024-01

2. Distinguishing EGFR mutant subtypes in stage IA non-small cell lung cancer using the presence status of ground glass opacity and final histologic classification: a systematic review and meta-analysis;Frontiers in Medicine;2023-12-06